AR232000A1 - Procedimiento para la obtencion de pancreatina - Google Patents

Procedimiento para la obtencion de pancreatina

Info

Publication number
AR232000A1
AR232000A1 AR295280A AR29528083A AR232000A1 AR 232000 A1 AR232000 A1 AR 232000A1 AR 295280 A AR295280 A AR 295280A AR 29528083 A AR29528083 A AR 29528083A AR 232000 A1 AR232000 A1 AR 232000A1
Authority
AR
Argentina
Prior art keywords
procedure
pancreatin
obtaining
obtaining pancreatin
Prior art date
Application number
AR295280A
Other languages
English (en)
Original Assignee
Nordmark Werke Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19823248587 external-priority patent/DE3248587A1/de
Priority claimed from DE19823248588 external-priority patent/DE3248588A1/de
Application filed by Nordmark Werke Gmbh filed Critical Nordmark Werke Gmbh
Application granted granted Critical
Publication of AR232000A1 publication Critical patent/AR232000A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/94—Pancreatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
AR295280A 1982-12-30 1983-12-28 Procedimiento para la obtencion de pancreatina AR232000A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19823248587 DE3248587A1 (de) 1982-12-30 1982-12-30 Verfahren zur gewinnung von pankreatin
DE19823248588 DE3248588A1 (de) 1982-12-30 1982-12-30 Verfahren zur gewinnung von pankreatin von hohem schuettgewicht

Publications (1)

Publication Number Publication Date
AR232000A1 true AR232000A1 (es) 1985-04-30

Family

ID=25807022

Family Applications (1)

Application Number Title Priority Date Filing Date
AR295280A AR232000A1 (es) 1982-12-30 1983-12-28 Procedimiento para la obtencion de pancreatina

Country Status (15)

Country Link
US (1) US4623624A (es)
EP (1) EP0115023B1 (es)
AR (1) AR232000A1 (es)
BR (1) BR8307280A (es)
CA (1) CA1208580A (es)
DD (1) DD212981A5 (es)
DE (1) DE3377506D1 (es)
DK (1) DK173599B1 (es)
ES (1) ES528537A0 (es)
HU (1) HU196435B (es)
MD (1) MD411C2 (es)
PL (1) PL141118B1 (es)
SU (1) SU1644712A3 (es)
UA (1) UA5996A1 (es)
YU (1) YU45584B (es)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100229754B1 (ko) * 1989-11-24 1999-11-15 샬러 한스, 하우스 한스 루돌프 판크레아틴구형입자, 이의 제조방법 및 이를 함유하는 약제학적 조성물
US5861291A (en) * 1997-02-24 1999-01-19 Biozymes Inc. Method for producing pancreatin which contains low amounts of residual organic solvent and product thereof
US6632429B1 (en) 1999-12-17 2003-10-14 Joan M. Fallon Methods for treating pervasive development disorders
KR100367659B1 (ko) * 2000-05-08 2003-01-14 주식회사 바이넥스 선택적 안정화제의 첨가에 따른 자가분해(autolysis)를 통한 고역가 판크레아틴의 제조방법
US20070053895A1 (en) 2000-08-14 2007-03-08 Fallon Joan M Method of treating and diagnosing parkinsons disease and related dysautonomic disorders
IT1319655B1 (it) 2000-11-15 2003-10-23 Eurand Int Microsfere di enzimi pancreatici con elevata stabilita' e relativometodo di preparazione.
US8030002B2 (en) 2000-11-16 2011-10-04 Curemark Llc Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions
CA2419572A1 (en) * 2003-02-18 2004-08-18 Axcan Pharma Inc. High dosage protease formulation
RU2359270C2 (ru) * 2003-07-29 2009-06-20 Зольвай Фармасьютиклз Гмбх Способ анализа панкреатита и содержащих его композиций
CA2560613C (en) * 2004-03-22 2015-11-24 Solvay Pharmaceuticals Gmbh Oral pharmaceutical compositions of lipase-containing products, in particular of pancreatin, containing surfactants
US7153504B2 (en) 2004-07-30 2006-12-26 Can Technologies, Inc. Stabilized pancreas product
MX2007013725A (es) 2005-05-05 2008-04-09 Sensient Flavors Inc Produccion de beta-glucanos y mananos.
HUE031042T2 (en) 2005-07-29 2017-06-28 Abbott Laboratories Gmbh Methods for producing pancreatin powder with low viral content
US9198871B2 (en) * 2005-08-15 2015-12-01 Abbott Products Gmbh Delayed release pancreatin compositions
US11266607B2 (en) * 2005-08-15 2022-03-08 AbbVie Pharmaceuticals GmbH Process for the manufacture and use of pancreatin micropellet cores
US20080058282A1 (en) 2005-08-30 2008-03-06 Fallon Joan M Use of lactulose in the treatment of autism
TW200745337A (en) * 2006-02-24 2007-12-16 Aminotech As Modified process
US10072256B2 (en) * 2006-05-22 2018-09-11 Abbott Products Gmbh Process for separating and determining the viral load in a pancreatin sample
US8246950B2 (en) 2007-02-20 2012-08-21 Aptalis Pharma Limited Stable digestive enzyme compositions
US20090130063A1 (en) * 2007-11-15 2009-05-21 Solvay Pharmaceuticals Gmbh Process for separating and determining the viral load in a pancreatin sample
WO2009109856A2 (en) 2008-03-07 2009-09-11 Axcan Pharma Inc. Method for detecting infectious parvovirus in pharmaceutical preparations
US8658163B2 (en) 2008-03-13 2014-02-25 Curemark Llc Compositions and use thereof for treating symptoms of preeclampsia
US8084025B2 (en) 2008-04-18 2011-12-27 Curemark Llc Method for the treatment of the symptoms of drug and alcohol addiction
US9320780B2 (en) 2008-06-26 2016-04-26 Curemark Llc Methods and compositions for the treatment of symptoms of Williams Syndrome
EP2318035B1 (en) * 2008-07-01 2019-06-12 Curemark, Llc Methods and compositions for the treatment of symptoms of neurological and mental health disorders
US10776453B2 (en) 2008-08-04 2020-09-15 Galenagen, Llc Systems and methods employing remote data gathering and monitoring for diagnosing, staging, and treatment of Parkinsons disease, movement and neurological disorders, and chronic pain
EP2165717A1 (de) * 2008-08-27 2010-03-24 Nordmark Arzneimittel GmbH & Co.KG Verfahren zur Verringerung der viralen und mikrobiellen Belastung feststoffhaltiger biologischer Extrakte
US20100092447A1 (en) 2008-10-03 2010-04-15 Fallon Joan M Methods and compositions for the treatment of symptoms of prion diseases
CA2747611C (en) 2009-01-06 2019-09-17 Curemark Llc Compositions and methods for the treatment or prevention of staphylococcus aureus infections and for the eradication or reduction of staphylococcus aureus on surfaces
WO2010080835A1 (en) 2009-01-06 2010-07-15 Curemark Llc Compositions and methods for the treatment or the prevention oral infections by e. coli
US9056050B2 (en) 2009-04-13 2015-06-16 Curemark Llc Enzyme delivery systems and methods of preparation and use
US9511125B2 (en) 2009-10-21 2016-12-06 Curemark Llc Methods and compositions for the treatment of influenza
UA111726C2 (uk) 2010-10-01 2016-06-10 Апталіс Фарма Лімітед Препарат панкреліпази низької сили з кишковорозчинним покриттям
JP5976100B2 (ja) 2011-04-21 2016-08-23 キュアマーク リミテッド ライアビリティ カンパニー 神経精神障害の処置のための化合物
CA2843556A1 (en) 2011-08-08 2013-02-14 Aptalis Pharma Ltd. Method for dissolution testing of solid compositions containing digestive enzymes
US10350278B2 (en) 2012-05-30 2019-07-16 Curemark, Llc Methods of treating Celiac disease
WO2015019198A2 (en) * 2013-07-22 2015-02-12 Aptalis Pharma S.R.L. High potency pancreatin pharmaceutical compositions
US20160108389A1 (en) * 2013-07-22 2016-04-21 Aptalis Pharma Ltd. High potency pancreatin pharmaceutical compositions
MX2016001593A (es) 2013-08-09 2016-09-29 Allergan Pharmaceuticals Int Ltd Composicion de enzima digestiva adecuada para administracion enterica.
MX2016000480A (es) * 2013-11-05 2016-10-21 Allergan Pharmaceuticals Int Ltd Composiciones farmaceuticas de pancreatina de alta potencia.
JP2017519490A (ja) 2014-06-19 2017-07-20 アプタリス ファルマ リミテッド 膵臓抽出物からのウイルス汚染の除去方法
WO2016071434A1 (en) 2014-11-05 2016-05-12 Abbott Laboratories Gmbh Processes for producing compositions with improved safety profile comprising pancreatin and compositions suitable for pharmaceutical use
US11278603B2 (en) 2016-03-28 2022-03-22 Abbvie Inc. Enzyme compositions with reduced viral and microbial contamination
BR112018070033A2 (pt) 2016-03-28 2019-02-05 Abbott Laboratories Gmbh preparação enzimática, método para produzir um produto de pancreatina, composição farmacêutica e método para tratar insuficiência pancreática exócrina
US12226464B2 (en) 2017-04-10 2025-02-18 Curemark, Llc Compositions for treating addiction
EA202090851A1 (ru) 2017-09-27 2020-08-07 Эбботт Лэбораториз Гмбх Ферментные композиции со сниженным уровнем вирусного и микробного загрязнения
CN108316036A (zh) * 2018-01-25 2018-07-24 陕西科技大学 一种豆渣制备微纤化纤维素的方法
US11541009B2 (en) 2020-09-10 2023-01-03 Curemark, Llc Methods of prophylaxis of coronavirus infection and treatment of coronaviruses
WO2024105193A1 (en) * 2022-11-17 2024-05-23 Koptyug Andrey V Novel compounds and methods

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB928654A (en) * 1960-10-25 1963-06-12 Philips Nv Improvements in or relating to the production of pancreatin
GB1328202A (en) 1969-06-17 1973-08-30 Union International Co Ltd Manufacture of pancreatin
DE2106706B2 (de) * 1971-02-12 1973-05-10 Wilson Pharmaceutical & Chemical Corp., Chicago, 111. (V.St.A.) Verfahren zur herstellung von pankreatin als trockenes pulver mit hoher proteolytischer, amylolytischer und lipolytischer aktivitaet
DE2620289C2 (de) * 1976-05-07 1982-05-19 A. Nattermann & Cie GmbH, 5000 Köln Herstellung eines lipasereichen Enzympräparates
US4088539A (en) 1976-05-07 1978-05-09 A. Nattermann & Cie Gmbh Process of manufacturing enzyme preparation rich in lipase

Also Published As

Publication number Publication date
BR8307280A (pt) 1984-08-07
EP0115023B1 (de) 1988-07-27
DK173599B1 (da) 2001-04-23
DE3377506D1 (en) 1988-09-01
DK605583A (da) 1984-07-01
HU196435B (en) 1988-11-28
UA5996A1 (uk) 1994-12-29
DD212981A5 (de) 1984-08-29
EP0115023A3 (en) 1986-04-09
SU1644712A3 (ru) 1991-04-23
DK605583D0 (da) 1983-12-29
CA1208580A (en) 1986-07-29
PL141118B1 (en) 1987-06-30
EP0115023A2 (de) 1984-08-08
YU45584B (sh) 1992-07-20
US4623624A (en) 1986-11-18
YU252483A (en) 1986-10-31
ES8407516A1 (es) 1984-09-16
MD411C2 (ro) 1996-06-30
PL245381A1 (en) 1984-10-22
ES528537A0 (es) 1984-09-16

Similar Documents

Publication Publication Date Title
AR232000A1 (es) Procedimiento para la obtencion de pancreatina
ES555049A0 (es) Procedimiento para la obtencion de arilciclopropil-cetonas
ES527714A0 (es) Procedimiento para la obtencion de tetrapeptidos sustituidos
ES543386A0 (es) Procedimiento para la obtencion de 1-heteroaril-4-aril-pira-zolin-5-onas
ES542207A0 (es) Procedimiento para la obtencion de tetrahidrofuran-2-ilmeti-laminas
ES533538A0 (es) Procedimiento para la obtencion de tetrahidropiridazinonas
ES520273A0 (es) Procedimiento para la obtencion de trimetilolpropano.
ES545967A0 (es) Procedimiento para la obtencion de poliarilensulfuro
ES516841A0 (es) Procedimiento para la obtencion de benzofuranonas
ES550219A0 (es) Procedimiento para la obtencion de aminopolieteres alcoxi- lados
ES549255A0 (es) Procedimiento para la obtencion de halogeno-hidroxi-flavonas
ES526042A0 (es) Procedimiento para la obtencion de azolilbutanoles
ES543820A0 (es) Procedimiento para la obtencion de piperacinil-oxo-quinoli- nas
ES533988A0 (es) Procedimiento para la obtencion de mercaptocarboxilamidas
ES549266A0 (es) Procedimiento para la obtencion de n-halo-carbonil-fenilhi- drazinas substituidas
ES525257A0 (es) Procedimiento para la obtencion de poliamido-imidas
ES522474A0 (es) Procedimiento para la obtencion de halogenopropargilformamidas.
ES546549A0 (es) Procedimiento para la obtencion de fluoralcoxifenilsulfonil-guanidinas
ES526672A0 (es) Procedimiento para la obtencion de latex cationicos
ES519809A0 (es) Procedimiento para la obtencion de oxazolidin-2-onas.
ES537129A0 (es) Procedimiento para la obtencion de iodacetamidas
ES546192A0 (es) Procedimiento para la obtencion de benzotiazolsulfenamidas
ES525507A0 (es) Procedimiento para la obtencion de 2-benzotiazolsulfenamidas estericamente impedidas
ES525995A0 (es) Procedimiento de obtencion de piridopirimidinonas
ES555532A0 (es) Procedimiento para la obtencion de benzotiopiranonas